It is a once-weekly subcutaneous injection indicated in combination with a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or who are overweight
While GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists can benefit many patients with type 2 diabetes or obesity, certain individuals face elevated risk for gallbladder complications and require careful consideration before initiating therapy
The CDC and clinical guidelines suggest that expecting 12 pounds weekly during the initial phase and 0.51 pound weekly during later phases represents a reasonable framework, though week-to-week fluctuations due to fluid retention, menstrual cycles, or dietary sodium intake are normal and should not cause alarm
If you have questions about medication storage or diabetes management, Doctronic can provide personalized guidance
This basic hygiene forms the bedrock of sterile technique, preventing contaminants from ever reaching your precious peptide